Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
INNOVUS PHARMACEUTICALS, INC. (INNV) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/13/2019 8-K Quarterly results
Docs: "Innovus Pharma Reports Quarterly Revenue for the Second Quarter 2019 of $6.8 million, a 27.7% Increase from Prior Quarter Sales & Marketing Expense as a Percentage of Total Revenue Declined to 41.7% for the three months ended June 30, 2019 Compared with 75.6% in Comparable Period in the Prior Year Reduced Operating Loss by 21% Compared with both the Prior Quarter and Comparable Quarter in the Prior Year SAN DIEGO, August 13, 2019 – Innovus Pharmaceuticals, Inc. , an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’s and women's health and respiratory diseases, announced today its reported results for the second quarter ended June 30, 2019. Financial highlights for the second qua..."
05/15/2019 8-K Quarterly results
Docs: "Innovus Pharma Reports Quarterly Revenue for the First Quarter 2019 of $5.4 million, a 18.0% Increase From Comparable Quarter in the Prior Year Cash, inclusive of merchant processor holdback, of $2.9 million as of May 13, 2019 SAN DIEGO, May 15, 2019 – Innovus Pharmaceuticals, Inc. , an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’ s and women's health and respiratory diseases, announced today its reported results for the three months ended March 31, 2019. Financial highlights for the three months ended March 31, 2019 compared to March 31, 2018 included: ■ Revenues of approximately $5.4 million, an increase of $0.8 million or 18.0% compared to prior year and $0.6 milli..."
04/01/2019 8-K Quarterly results
Docs: "Innovus Pharma Reports Record Annual Revenue for Fiscal 2018 of $24.0 million in line with Previous Guidance and Product Gross Margins of 81%"
11/14/2018 8-K Quarterly results
Docs: "Innovus Pharma Reports Another New Quarterly Revenue Record of Approximately $7.4 million for the Third Quarter 2018 and $19.2 million for the First Nine Months of 2018"
05/14/2018 8-K Quarterly results
04/02/2018 8-K Quarterly results
Docs: "Innovus Pharmaceuticals Reports Record Annual Revenue for Fiscal 2017 of $8.8 Million, Preliminary Q1 2018 Revenue of $4.3 million to $4.4 million and Expects to Exit 2018 Profitable Year over Year Revenue Increase of 83% with Reduction in Net Loss of 53% in 2017 and Fiscal Year 2018 Net Revenue Annual Run Rate of At Least $18 million SAN DIEGO, April 2, 2018 – Innovus Pharmaceuticals, Inc., , today announced full year 2017 net revenue of $8.8 million compared to $4.8 million in revenue for the same period in 2016 and fourth quarter of 2017 net revenue of $2.4 million compared to $1.7 million in revenue for the same period in 2016. Preliminary first quarter 2018 net revenue is estimated to be between $4.3 million to $4.4 million or an approximate 85% increase from the fourth quarter of 201..."
08/14/2017 8-K Quarterly results
05/12/2017 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy